⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL477969 | 1.00 | — | — | |
| SCHEMBL477720 | 1.00 | — | — | |
| SCHEMBL765922 | 0.78 | — | — | |
| SCHEMBL533226 | 0.78 | — | — | |
| SCHEMBL4495282 | 0.75 | — | — | |
| SCHEMBL1450906 | 0.75 | — | — | |
| Hydrochloric Acid SCHEMBL28282660 | 0.75 | — | — | |
| SCHEMBL4447966 | 0.75 | — | — | |
| Methyl Alcohol SCHEMBL365291 | 0.75 | — | — | |
| SCHEMBL9476213 | 0.74 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 31 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0120242-B1 | PROCESS FOR COATING A SUBSTRATE WITH POLYIMIDE | International Business Machines Corporation (US) | 1987-01-07 | — | — | EP | claimed |
| WO-2024053650-A1 | COMPOUND HAVING INHIBITORY ACTIVITY AGAINST DIACYLGLYCEROL KINASE α AND/OR ζ, AND PHARMACEUTICAL USE THEREOF | 小野薬品工業株式会社 | 2024-03-14 | — | — | WO | disclosed |
| CN-116947890-A | Tricyclic compound of WEE1 inhibitor, and preparation method and application thereof | 星希尔生物科技(上海)有限公司 | 2023-10-27 | — | — | CN | disclosed |
| CN-116836157-A | Oxadiazole derivative and preparation method and application thereof | 星希尔生物科技(上海)有限公司 | 2023-10-03 | — | — | CN | disclosed |
| WO-2023179366-A1 | OXADIAZOLE DERIVATIVE, PREPARATION METHOD THEREFOR AND USE THEREOF | 星希尔生物科技(上海)有限公司 | 2023-09-28 | — | — | WO | disclosed |
| US-20230014137-A1 | COMPOUND HAVING LYSOPHOSPHATIDIC ACID RECEPTOR AGONIST ACTIVITY AND PHARMACEUTICAL USE THEREOF | ONO PHARMACEUTICAL CO., LTD. (JP) | 2023-01-19 | — | — | US | disclosed |
| WO-2021107125-A1 | COMPOUND HAVING LYSOPHOSPHATIDIC ACID RECEPTOR AGONISTIC ACTIVITY AND PHARMACEUTICAL USE OF SAID COMPOUND | 小野薬品工業株式会社 | 2021-06-03 | — | — | WO | disclosed |
| US-10336718-B2 | Method for industrial production of optically active fluoroalkyl ethylene oxide | CENTRAL GLASS COMPANY, LIMITED (JP) | 2019-07-02 | — | — | US | disclosed |
| US-20180312483-A1 | Method for Industrial Production of Optically Active Fluoroalkyl Ethylene Oxide | CENTRAL GLASS COMPANY, LIMITED (JP) | 2018-11-01 | — | — | US | disclosed |
| WO-2015091931-A1 | OXINDOLE DERIVATIVES CARRYING A PIPERIDYL-SUBSTITUTED AZETIDINYL SUBSTITUENT AND USE THEREOF FOR TREATING VASOPRESSINE-RELATED DISEASES | AbbVie Deutschland GmbH & Co. KG (DE) | 2015-06-25 | — | — | WO | disclosed |
| US-20120015975-A1 | FUSED HETEROCYCLIC COMPOUND AND USE THEREOF | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2012-01-19 | — | — | US | disclosed |
| US-7956041-B2 | antidiabetic mixture contains an inhibitor of renal glucose reabsorption and a hypoglycemic agent; controlling blood glucose level; tolbutamide, chlorpropamide, glibenclamide, glipizide, glimepiride, and gliclazide; metformin, phenformin and buformin; repaglinide, nateglinide and mitiglinide | AJINOMOTO CO., INC. (JP) | 2011-06-07 | — | — | US | disclosed |
| US-7592386-B2 | Dual cure hydrotalcite containing fluoropolymer compositions | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2009-09-22 | — | — | US | disclosed |
| US-7402630-B2 | Curing compositions for fluoropolymers | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2008-07-22 | — | — | US | disclosed |
| US-20080116603-A1 | DUAL CURE HYDROTALCITE CONTAINING FLUOROPOLYMER COMPOSITIONS | 3M INNOVATIVE PROPERTIES COMPANY | 2008-05-22 | — | — | US | disclosed |
| US-20050143424-A1 | Prophylactic and therapeutic agent of diabetes mellitus | AJINOMOTO CO. INC (JP) | 2005-06-30 | — | — | US | disclosed |
| EP-1500403-A1 | PREVENTIVE/REMEDY FOR DIABETES | Ajinomoto Co., Inc. (JP) | 2005-01-26 | — | — | EP | disclosed |
| US-6593319-B1 | Novel 17,20-dihydrofusidic acid derivatives are used in pharmaceutical compositions for the treatment of infections, in particular in topical compositions for the treatment of skin or eye infections. | LEO PHARMACEUTICAL PRODUCTS, LTD. A/S (DK) | 2003-07-15 | — | — | US | disclosed |
| EP-0042991-B1 | CARBONYL-AMINO-URETHANES AND HERBICIDAL AND FUNGICIDAL COMPOSITIONS CONTAINING THEM | BASF Aktiengesellschaft (DE) | 1983-07-13 | — | — | EP | disclosed |
| EP-0042991-A1 | Carbonyl-amino-urethanes and herbicidal and fungicidal compositions containing them | BASF Aktiengesellschaft (DE) | 1982-01-06 | — | — | EP | disclosed |